选择性激光小梁成形术治疗硅油性继发性青光眼的临床结果
Clinical results of selective laser trabeculoplasty in silicone oil-induced secondary glaucoma.
作者信息
Zhang Miaomiao, Li Bin, Wang Jianrong, Liu Wei, Sun Yan, Wu Xinyi
机构信息
Department of Ophthalmology, Qilu Hospital of Shandong University, 107# Wenhua Xi Road, Jinan, 250012, People's Republic of China.
出版信息
Graefes Arch Clin Exp Ophthalmol. 2014 Jun;252(6):983-7. doi: 10.1007/s00417-014-2593-7. Epub 2014 Mar 27.
BACKGROUND
To analyze the efficacy of selective laser trabeculoplasty (SLT) on silicone oil-induced secondary glaucoma in terms of intraocular pressure (IOP).
PATIENTS AND METHODS
42 patients (42 eyes) with silicone oil-induced secondary glaucoma were selected, and SLT was performed with 360° of the trabecular meshwork. During the 12-month follow-up, the complications, IOP, and antiglaucoma medication usage were observed.
RESULTS
The mean IOP decreased from 23.1 ± 1.9 mmHg before treatment to 18.4 ± 3.7 mmHg after treatment (p < 0.05). Mean number of antiglaucoma medications used for IOP control also decreased from 2.17 ± 1.21 to 1.25 ± 0.89 (p < 0.05). The 12-month success rate in the total sample was 59.5 %. The success rate was 60.7 % (17 eyes) and 57.1 % (eight eyes) for phakic and aphakic eyes, respectively (p > 0.05) CONCLUSIONS: SLT is a safe and effective option for the treatment of patients with silicone oil-induced secondary glaucoma.
背景
从眼压（IOP）方面分析选择性激光小梁成形术（SLT）治疗硅油性继发性青光眼的疗效。
患者与方法
选取42例（42眼）硅油性继发性青光眼患者，对小梁网进行360°的SLT治疗。在12个月的随访期间，观察并发症、眼压及抗青光眼药物使用情况。
结果
治疗前平均眼压为23.1±1.9 mmHg，治疗后降至18.4±3.7 mmHg（p<0.05）。用于眼压控制的抗青光眼药物平均使用数量也从2.17±1.21降至1.25±0.89（p<0.05）。总样本的12个月成功率为59.5%。有晶状体眼和无晶状体眼的成功率分别为60.7%（17眼）和57.1%（8眼）（p>0.05）。结论：SLT是治疗硅油性继发性青光眼患者的一种安全有效的选择。
Zotero 插件